Asthma Clinical Trials in Columbia, Missouri

4 studies are recruiting for asthma in Columbia, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

    The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

    Stage
    Phase 3
    Ages
    12 to 17
    Site
    GSK Investigational Site, Columbia, Missouri
    Locations
    67 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT05757102 on ClinicalTrials.gov

  2. A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

    The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety …

    Stage
    Phase 3
    Ages
    12 and older
    Site
    Teva Investigational Site 12149, Columbia, Missouri
    Locations
    189 in total
    Run by
    Teva Branded Pharmaceutical Products R&D LLC

    See if you can join NCT06664619 on ClinicalTrials.gov

  3. A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

    The purpose of this study is to evaluate the effect of 2 different GP metered dose inhaler (MDI) doses relative to placebo MDI as add-on treatment to BFF MDI on lung function in participants 4 to less than 12 years of age with asthma.

    Stage
    Phase 2
    Ages
    4 to 11
    Site
    Research Site, Columbia, Missouri
    Locations
    43 in total
    Run by
    AstraZeneca

    See if you can join NCT07525375 on ClinicalTrials.gov

  4. Individualizing Treatment for Asthma in Primary Care (Full Study)

    While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long…

    Stage
    Phase 4
    Ages
    13 to 75
    Site
    University of Missouri, Columbia, Missouri
    Locations
    13 in total
    Run by
    DARTNet Institute

    See if you can join NCT07052942 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.